000			01946 a2200553 4500
005			20250515214435.0
264		0	_c20110211
008			201102s 0 0 eng d
022			_a1536-4844
024	7		_a10.1002/ibd.21258 _2doi
040			_aNLM _beng _cNLM
100	1		_aAndus, Tilo
245	0	0	_aClinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis. _h[electronic resource]
260			_bInflammatory bowel diseases _cNov 2010
300			_a1947-56 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage
650	0	4	_aColitis, Ulcerative _xdrug therapy
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMesalamine _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aPatient Preference
650	0	4	_aProctitis _xdrug therapy
650	0	4	_aRemission Induction
650	0	4	_aSingle-Blind Method
650	0	4	_aSuppositories
650	0	4	_aYoung Adult
700	1		_aKocjan, Andreas
700	1		_aMüser, Moritz
700	1		_aBaranovsky, Andrey
700	1		_aMikhailova, Tatyana L
700	1		_aZvyagintseva, Tatyana D
700	1		_aDorofeyev, Andrey E
700	1		_aLozynskyy, Yurii S
700	1		_aCascorbi, Ingolf
700	1		_aStolte, Manfred
700	1		_aVieth, Michael
700	1		_aDilger, Karin
700	1		_aMohrbacher, Ralf
700	1		_aGreinwald, Roland
773	0		_tInflammatory bowel diseases _gvol. 16 _gno. 11 _gp. 1947-56
856	4	0	_uhttps://doi.org/10.1002/ibd.21258 _zAvailable from publisher's website
999			_c19673198 _d19673198